US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 7.350
  • -0.050-0.68%
Close Apr 19 16:00 ET
  • 7.220
  • -0.130-1.77%
Post 19:57 ET
1.72BMarket Cap-4651P/E (TTM)

Recursion Pharmaceuticals Key Stats

Recursion Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 27, 2024

Revenue(YoY)

10.89M

-20.36%
EPS(YoY)

-0.42

-35.48%

Buy

Mar 31, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 13.583M--
--2024/Q1-- / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--
--2022/Q15.333M / 83.950M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 13.583M--
--2024/Q1-- / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--
--2022/Q15.333M / 83.950M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    33.33%
  • Hold

    66.67%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg